BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2018
View Archived Issues
Shionogi reviews highlights of third quarter of fiscal 2017
Read More
MSK1 shown as a new prognostic biomarker in ER+ breast cancer
Read More
Novel multifunctional vehicle strategy for delivering Cas9-sgRNAs into tumor cells
Read More
Takeda updates clinical progress of third quarter of fiscal 2017
Read More
INSERM and collaborators patent stromal cell-derived factor 1 inhibitors
Read More
Bayer divulges novel TASK-1/3 blockers
Read More
Ensoltek describes new peptides acting as RAGE receptor ligands
Read More
Advanced Proteome Therapeutics and ImmunoBiochem to collaborate on antibody-drug conjugates
Read More
Iovance Biotherapeutics discloses new PD-L1 binding proteins
Read More
Bexsero receives second breakthrough therapy designation from the FDA
Read More
Novel monoclonal antibodies targeting VE-PTP synthesized at Aerpio Pharmaceuticals
Read More
Novel influenza vaccine induces robust long-lasting immunity in mice
Read More
Amgen reports product advances for 2017
Read More
Ono Pharmaceutical updates key events of third quarter of fiscal 2017
Read More
Janssen describes characterization of clinical candidate P2X7 antagonist for mood disorders
Read More
Top-line results for ACTION 2 study of natalizumab in acute ischemic stroke
Read More
Researchers present phase II data from NabucCO trial on metastatic pancreatic cancer
Read More
Verastem submits NDA for duvelisib
Read More
FDA approves Biktarvy to treat HIV-1 infection
Read More
Case Western, Sangamo awarded grant to advance research on gene-edited T cells to treat HIV
Read More
Xcovery starts phase II trial for ensartinib in melanoma patients with ALK alterations
Read More
Sage Therapeutics' SAGE-217 given FDA breakthrough therapy designation for major depressive disorder
Read More
Aviragen and Vaxart agree to amend merger agreement
Read More
YL Biologics reports successful completion of phase III trial of etanercept biosimilar YLB-113
Read More
Silenseed initiates phase II study of siG12D LODER in locally advanced pancreatic cancer
Read More
Insmed studies INS-1007 in phase II for non-cystic fibrosis bronchiectasis
Read More
Symic Biomedical reports MODIFY2 phase II trial results of SB-061 for knee osteoarthritis
Read More
GlaxoSmithKline initiates first-in-human study of GSK-2983559
Read More